)
Edge11 Sep 2026
Texas Pacific Land Corporation: Keeper of the Permian Basin
Land once granted to a failed 19th-century railroad now generates royalties for Texas Pacific Land Corporation across the Permian Basin.
ImpediMed
ImpediMed (IPD) investor relations material
ImpediMed H2 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.H2 2026 earnings summary26 Aug, 2026
Executive summary
Revenue increased 15% year-over-year to $14.6 million, with 20% growth in constant currency and 95% U.S. reimbursement coverage for breast cancer-related lymphoedema.
SOZO® Pro platform expanded into Heart Health and Weight Management, both in early commercial stages.
Leadership transition: Dr Parmjot Bains stepped down as CEO, succeeded by Erik Anderson in April 2026.
$15.3 million equity raise completed, $5.0 million used to partially repay debt, and $5.0 million in annualised operating cost reductions implemented.
Financial highlights
Total revenue: $14.6 million, up 15% from FY25; $15.3 million in constant currency, up 20%.
Gross margin improved to 87% from 86% in FY25.
Net loss from operations: $24.9 million, compared to $23.2 million in FY25, mainly due to higher finance expenses.
Cash and cash equivalents at year-end: $15.3 million (down from $22.2 million in FY25).
Net cash used in operating activities: $17.9 million (vs. $15.6 million in FY25).
SOZO Core Business ARR: $14.4 million at 30 June 2026; churn rate 6.8%.
Outlook and guidance
FY27 priorities: deepen lymphoedema and survivorship platform, drive utilisation and growth in current accounts, scale Heart Health and Weight Management, and progress toward cash flow breakeven.
Platform positioned for continued growth with expanding clinical guideline support and reimbursement.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from ImpediMed
- Q4 FY26 delivered revenue growth, record cash receipts, and expanded reimbursement coverage.IPD
Q4 2026 - Shareholders approved a major capital raise to fund growth and reduce debt, with results pending.IPDEGM 2026
- $15.2M equity raise funds SOZO®-driven US expansion, targeting FY28 cashflow breakeven.IPDInvestor presentation
- A$15.2 million capital raise and cost cuts set a path to breakeven by FY28.IPDTrading update
- Q3 FY26 revenue reached $3.5M, with expanded US reimbursement and new CEO appointed.IPDQ3 2026
- New CEO appointed to drive U.S. growth as Q3 shows solid sales and ongoing cost discipline.IPDInvestor update
- Revenue up 25% to $7.5M, with strong recurring growth and expanded US reimbursement.IPDH1 2026
- Q2 revenue hit $3.9M, ARR $14.4M, BCRL coverage 92.8%, SOZO Pro launched, 6.5 quarters funding.IPDQ2 2026
- SOZO Core Business and ARR grew 14% and 18% despite a 9% revenue drop, with break-even targeted by July 2025.IPDH2 2024
Next ImpediMed earnings date
Q1 202727 Oct, 2026
ImpediMed
Next ImpediMed earnings date
Q1 202727 Oct, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage